Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Simulations Plus Inc SLP

Healthcare Medical Devices
Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. The Company's segments include software and services. It offers 12 software products for pharmaceutical research and development... see more

Recent & Breaking News (NDAQ:SLP)

New Research Coverage Highlights Famous Dave's of America, Great Elm Capital Group, Otelco, Simulations Plus, SilverSun Technologies, Inc., and ENGlobal — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire November 19, 2018

Simulations Plus Reports FY2018 and Fourth Quarter FY2018 Financial Results

Business Wire November 14, 2018

Simulations Plus to Report 4th Quarter and Fiscal Year 2018 Financial Results

Business Wire November 7, 2018

DILIsym Services, an SLP Company, Launches Consortium for Drug-Related Kidney Injury

Business Wire November 6, 2018

Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share

Business Wire October 22, 2018

Simulations Plus Receives New Grant Award from the FDA

Business Wire September 12, 2018

Simulations Plus Extends Funded Research Collaboration with the FDA

Business Wire September 5, 2018

Simulations Plus Subsidiary DILIsym Awarded Grant for up to $1.7 Million For Model Development

Business Wire July 23, 2018

Simulations Plus Enters Funded Research Collaboration with Large European Consortium

Business Wire July 18, 2018

Simulations Plus Reports Third Quarter FY2018 Financial Results

Business Wire July 10, 2018

Company Profile for Simulations Plus, Inc.

Business Wire July 3, 2018

Simulations Plus to Report Third Quarter 2018 Financial Results

Business Wire July 3, 2018

Simulations Plus Releases ADMET Predictor™ Version 9

Business Wire June 28, 2018

Simulations Plus Names Shawn O’Connor as CEO

Business Wire June 26, 2018

Simulations Plus to Present at the 8th Annual LD Micro Invitational Investor Conference on June 5, 2018

Business Wire June 1, 2018

Simulations Plus Releases GastroPlus™ Version 9.6

Business Wire May 23, 2018

Simulations Plus to Present at the Needham Emerging Technology Conference on May 16, 2018

Business Wire May 15, 2018

US FDA Procures DILIsym Software License Package

Business Wire May 8, 2018

Simulations Plus Announces Employee Bonuses

Business Wire April 24, 2018

Simulations Plus Announces Senior Management Changes

Business Wire August 31, 2017